Saved by Leeches: One Man’s 8‑Year Battle with Chronic Pelvic Pain and the Treatment That Finally Worked

Date: May 12, 2026
Published by: Jingzhou MinKang Biotechnology Co., Ltd.
Section: Patient Case Study

David (not his real name) was 34 years old when his life fell apart. A former semi‑professional cyclist and father of three from Melbourne, Australia, he had always enjoyed an active, healthy lifestyle. Then, one ordinary afternoon, he felt a strange, gnawing discomfort deep in his pelvis—like the dull ache that follows a long ride, but without having been on a bike.

That was eight years ago.

Over the next eight years, he would see seven urologists, try five different antibiotics, spend countless nights lying awake from 9‑out‑of‑10 pain, and be told by more than one specialist, “There‘s nothing structurally wrong with you. Maybe it’s just stress.”

His diagnosis: chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) —a debilitating condition of persistent pelvic pain, urinary urgency, and sexual dysfunction with no clear infection or anatomical cause. According to the Urology Care Foundation, it affects 5‑10% of men worldwide, yet it remains one of the most frustrating and under‑treated conditions in modern medicine.

This is the story of what happened when David ran out of options—and how a 2,000‑year‑old therapy, backed by modern clinical case studies and high‑quality Hirudo nipponica leech powder, finally gave him his life back.

Meet David: A Classic Case of CP/CPPS

David‘s symptoms began subtly in early 2018. He noticed a persistent dull ache in his perineum (the area between the scrotum and anus), frequent urges to urinate with little output, and a burning sensation after ejaculation. Over time, the pain radiated to his lower abdomen, inner thighs, and lower back.

“Sitting was the worst,” he recalls. “I had to buy a donut cushion just to get through a workday. Even then, by 3 PM, the pain was so bad I could barely focus.”

Standard diagnostic workup revealed nothing: multiple urine cultures were negative, prostate‑specific antigen (PSA) was normal, and a transrectal ultrasound showed no structural abnormalities. His urologist diagnosed CP/CPPS by exclusion.

The treatment marathon began:

• Antibiotics (multiple courses) – No effect

• Alpha‑blockers (tamsulosin) – Slight improvement in urinary flow, but pelvic pain unchanged

• Anti‑inflammatories (ibuprofen, celecoxib) – Temporary relief at best

• Pelvic floor physical therapy – Helped a little, but expensive and time‑consuming

• Gabapentin (for neuropathic pain) – Caused intolerable drowsiness

The pain gradually worsened. On the Visual Analogue Scale (VAS)—where 0 is no pain and 10 is the worst imaginable—David rated his baseline at 8‑9. “There were nights I just lay there, staring at the ceiling, wondering if I’d ever feel normal again,” he says.

His National Institutes of Health Chronic Prostatitis Symptom Index (NIH‑CPSI) score, a standard measure of CP/CPPS severity, was 31 out of 43—indicating severe symptoms.

The Breaking Point: Searching Beyond Conventional Medicine

By 2024, David had grown despondent. His marriage was strained, he’d withdrawn from social activities, and his GP had started prescribing opioids, which barely touched the pain.

Frustrated, David began searching online for anyone else who had recovered from CP/CPPS after mainstream medicine had failed. Late one night, he came across a case report from Turkey published in 2023. The report described three men with CP/CPPS—all with pain levels of 9/10 before treatment—who underwent medicinal leech therapy (hirudotherapy).

The results caught his attention:

• Patient 1 improved from a pain score of 9 to 3

• Patient 2 improved from 9 to 4

• Patient 3 improved from 9 to 4

• NIH‑CPSI total scores improved by 31%, 79%, and 62% respectively

• No serious side effects occurred other than localized itching

“I’d never heard of using leeches for pelvic pain,” David admits. “But when you’ve been in agony for years, you stop caring about what’s ‘weird’ and start caring about what works.”

He also found a systematic review published in the African Journal of Urology that examined 13 unique cases of hirudotherapy across various urological conditions, all of which (100%) reported clinical improvement. While those cases ranged from penile replantation to post‑operative scrotal hematoma, the review confirmed what the Turkish case report suggested: for certain urological conditions involving venous congestion, inflammation, and circulatory impairment, medicinal leech therapy can be remarkably effective.

Encouraged, David approached his urologist—who was initially “extremely skeptical”—but ultimately agreed to supervise a monitored trial with high‑quality, standardized medicinal leech powder from a GAP‑certified facility.

The Treatment Protocol

The regimen was based on the published Turkish case series, which involved multiple application sessions targeting the perineal and lower abdominal regions:

• Patient age range: 20–46 years (David was 42 at the start)

• Treatment protocol: 4–8 leeches applied per session, with sessions repeated at intervals

• Duration: 4 weeks (David ultimately required 6 weeks)

• Application sites: Perineum, suprapubic area, and lumbosacral region

In the Turkish study, patients experienced progressive improvement over multiple sessions, with the most dramatic pain reduction occurring after the second or third application. David followed a similar schedule: two sessions per week for six weeks, with each session lasting approximately 60–90 minutes.

David also continued his low‑dose amitriptyline (for neuropathic pain) during the initial weeks of treatment, intending to taper it if leech therapy proved effective.

The Results: A Life‑Changing Turnaround

Week 2 (after 4 sessions)

“After the second session, I felt something I hadn‘t felt in years—my pelvic muscles started to relax,” David says. His VAS pain score dropped from 8 to 5. Urinary frequency decreased from 12–14 times per day to 8–9.

Week 4 (after 8 sessions)

By the fourth week, David was sleeping through the night for the first time in memory. His VAS score fell to 3. He began tapering amitriptyline.

Week 6 (after 12 sessions)

At the conclusion of the full protocol, David’s results were remarkable:

“My urologist called it ‘unexpected but very impressive,’” David laughs. “I think he was genuinely surprised.”

6 Months Later

David continues on a reduced maintenance schedule (one session every 2–3 weeks). His most recent assessment shows sustained improvement: VAS pain score of 2–3, NIH‑CPSI of 12, and the ability to work full‑time without a special cushion. He has even started gentle cycling again—something he hadn’t done in six years.

“I’m not saying I’m cured,” he emphasizes. “CP/CPPS doesn’t have a cure. But I’m functional again. I can play with my kids. I can sit through a movie. That’s everything.”

How Does Leech Therapy Work for Chronic Pelvic Pain?

The therapeutic effects observed in David’s case—and in the Turkish case series—are supported by the bioactive compounds found in medicinal leech saliva, particularly Hirudo nipponica (Japanese medicinal leech).

Unlike the European medicinal leech (Hirudo medicinalis), Japanese medicinal leech has been used in Asian traditional medicine for centuries and is increasingly recognized in Western research for its unique bioactive profile. The key mechanisms include:

1. Breaking the Cycle of Pelvic Congestion

Many men with CP/CPPS have pelvic venous congestion—stagnant, poorly circulating blood in the pelvic veins that contributes to chronic inflammation and pain.

Hirudin, the powerful thrombin inhibitor in leech saliva, works directly and potently—unlike heparin, which requires antithrombin III to function. This anticoagulant effect helps break down microthrombi in congested pelvic vessels, restoring normal blood flow and reducing the “heavy, full” sensation characteristic of CP/CPPS.

2. Reducing Inflammation in the Pelvic Floor

The pelvis is crisscrossed by nerves that become hypersensitive in CP/CPPS. Leech saliva contains eglin and anti‑stasin—natural protease inhibitors that neutralize inflammatory enzymes (like elastase and cathepsin G) responsible for ongoing tissue inflammation.

By inhibiting NF‑κB signaling—the master molecular switch for inflammation—these compounds help calm the inflammatory environment that keeps pelvic nerves in a state of hyperexcitability.

In the Turkish case series, all three patients experienced significant reductions in pain and NIH‑CPSI scores with no side effects beyond localized itching—a testament to the targeted, local anti‑inflammatory action of leech therapy.

3. Local Mechanical Decompression

Unlike oral medications that affect the entire body, leech therapy provides direct, localized relief. Each leech removes 5–15 mL of venous blood and interstitial fluid during feeding, reducing tissue pressure in the pelvic region. The anticoagulants in leech saliva extend this effect, with continued capillary oozing for several hours post‑application—prolonging the decongestive effect.

4. Improving Microcirculation in the Pelvis

Poor microcirculation is a hallmark of CP/CPPS. Leech saliva contains hyaluronidase (which breaks down extracellular matrix components, improving tissue permeability) and histamine‑like vasodilators (which open up small blood vessels). Together, these compounds increase blood flow velocity and enhance oxygen delivery to the pelvic tissues—creating an environment conducive to healing.

5. Natural Analgesic Effects

Many CP/CPPS patients (including David) also report direct pain relief during and immediately after leech application. This may be due to local anesthetic‑like compounds in leech saliva that act on peripheral nerve endings in the skin and underlying tissues, providing rapid, targeted pain relief—without the systemic side effects of oral analgesics.

Why David’s Success Depended on Quality Raw Material

David’s remarkable improvement was not accidental. He used leech powder sourced from Jingzhou MinKang Biotechnology Co., Ltd.—one of the few GAP‑certified medicinal leech producers in China specializing in Hirudo nipponica (Japanese medicinal leech). Why does that matter so critically?

Species authenticity matters. Not all commercially available “medicinal leeches” are the right species. Hirudo nipponica has a unique bioactive profile that makes it particularly suitable for applications involving pelvic microcirculation and inflammation. Adulterated or misidentified species often have inconsistent—or zero—bioactivity.

Consistent enzyme activity saves lives. Leech therapy’s effectiveness depends on stable, predictable concentrations of hirudin, eglin, and hyaluronidase in every batch. Leeches raised in uncontrolled conditions produce inconsistent enzyme levels—meaning results are unpredictable.

Freedom from contaminants is non‑negotiable. Leeches harvested from the wild or from poorly managed farms can carry heavy metals, pesticides, and pathogens that cause serious infections. In David’s case, sterile, controlled breeding environments and batch‑by‑batch independent testing guaranteed that the leeches were free of these hazards.

Jingzhou MinKang’s third‑party test reports confirm antithrombin activity exceeding 1700 U/g—well over 100 times the Chinese Pharmacopoeia minimum—along with heavy metal levels far below permissible limits and complete absence of aflatoxins. Every batch is traceable and independently verified.

“I knew nothing about any of this when I started,” David admits. “But my doctors helped me understand—if the raw material isn’t right, nothing works. I was lucky to get the real thing.”